We tested the ability of CD34+lin- precursor cells isolated from marrow after treatment with 4-hydroperoxycyclophosphamide (4HC) to generate colony-forming cells (CFC). In liquid cultures, recombinant human stem cell factor (SCF), in combination with interleukin-1 (IL-1), IL-3, IL- 6, granulocyte-macrophage colony-stimulating factor, or granulocyte colony-stimulating factor caused untreated, but not 4HC-treated, CD34+lin- cells to form CFC. However, generation of CFC from CD34+lin- cells treated with 60 micrograms/mL of 4HC was possible in the presence of an irradiated allogeneic stromal cell layer. This generation was increased when combinations of hematopoietic growth factors including SCF and IL-3 were added. Maximal generation of CFC was seen after 11 to 21 days of culture. At that time, generation of CFC from CD34+lin- 4HC- treated cells equalled that from untreated cells. The phenotype of these 4HC-resistant CD34+lin- precursors was also further defined as CD38-. These studies show that the generation of CFC from the 4HC- resistant, highly immature population of CD34+lin- cells requires an as yet undefined interaction with marrow stroma in addition to known hematopoietic growth factors.
Skip Nav Destination
ARTICLES|
July 1, 1993
Hematopoietic precursors resistant to treatment with 4- hydroperoxycyclophosphamide: requirement for an interaction with marrow stroma in addition to hematopoietic growth factors for maximal generation of colony-forming activity
SD Rowley,
SD Rowley
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98104.
Search for other works by this author on:
C Brashem-Stein,
C Brashem-Stein
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98104.
Search for other works by this author on:
R Andrews,
R Andrews
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98104.
Search for other works by this author on:
ID Bernstein
ID Bernstein
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98104.
Search for other works by this author on:
Blood (1993) 82 (1): 60–65.
Citation
SD Rowley, C Brashem-Stein, R Andrews, ID Bernstein; Hematopoietic precursors resistant to treatment with 4- hydroperoxycyclophosphamide: requirement for an interaction with marrow stroma in addition to hematopoietic growth factors for maximal generation of colony-forming activity. Blood 1993; 82 (1): 60–65. doi: https://doi.org/10.1182/blood.V82.1.60.bloodjournal82160
Download citation file:
July 1 1993
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal